Rua Bioscience Results - NZX template

Results for announcement to the market
Name of issuer Rua Bioscience Limited
Reporting Period 12 months to 30 June 2024
Previous Reporting Period 12 months to 30 June 2023
Currency NZD
Amount (000s) Percentage change
Revenue from continuing
operations
$322 -5 3%
Total Revenue $322 -5 3%
Net profit/(loss) from continuing
operations
($ 13,725) -130%
Total net profit/(loss) ($ 13,725) -130%
Interim/Final Dividend
Amount per Quoted Equity Security No dividend has been declared
Imputed amount per Quoted Equity
Security
N/A
Record Date N/A
Dividend Payment Date N/A
Current period Prior comparable period
Net tangible assets per Quoted
Equity Security
$0.03 $0.06
A brief explanation of any of the
figures above necessary to enable
the figures to be understood
Rua’s FY24 performance is set out in the company’s Investor Presentation
attached to this announcement, which provides detail and explanatory
comment on: operating and financial performance of the business and various
other relevant aspects of the financial performance for the year ended 30 June
2024. No dividend has been declared for this period.
Authority for this announcement
Name of person authorised to make
this announcement
Paul Naske, Chief Executive Officer
Contact person for this
announcement
Paul Naske, Chief Executive Officer
Contact phone number +64 21 445 154
Contact email address paul.naske@ruabio.com
Date of release through MAP 29/08/2024

Audited financial statements accompany this announcement.

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com



Results Announcement